Joint call for proposals for HIV, HBV and HDV cure research

Opening date: 26 October 2026 - Submission deadline: 12 January 2027

Last updated on 19 October 2026

Main points

  • ANRS Emerging infectious diseases (ANRS MIE) and the German Center for Infection Research (DZIF) are launching a joint call for proposals to support innovative translational and preclinical research on a cure for HIV, hepatitis B virus (HBV) and hepatitis Delta virus (HDV).
  • This call aims to encourage scientific collaboration between France and Germany by promoting cooperation between institutions, research teams and stakeholders in both countries.

About the call for proposals

ANRS MIE and DZIF have identified accelerating HIV and hepatitis cure research as a shared strategic priority. Through this jointly funded call, the two institutions also seek to strengthen long-term Franco-German scientific collaboration.

Scientific priorities and scope of the call

The proposed research must focus on a cure for HIV and/or hepatitis B and/or D, with a strong scientific rationale explaining how the proposed strategy could lead to a functional cure or viral eradication. It must also outline a clear translational pathway, showing how the research could ultimately lead to clinical application. Finally, it must propose an innovative approach that could advance research in this field.

Projects that do not explicitly focus on a cure for HIV and/or HBV/HDV, or that lack a clearly defined translational perspective, are not eligible.

The review committee will give favourable consideration to projects coordinated by an early-career or newly established researcher, as well as those involving a partnership with a pharmaceutical or biotechnology company.

Key dates and information

  • Call opening date: 26 October 2026
  • Submission deadline: 12 January 2027 at 23:59 CET
  • Notification of results: May 2027
  • Total call budget: €2 million
  • Budget per project: between €300,000 and €500,000
  • Project duration: 24 or 36 months

Introductory webinar on the joint call for proposals: date to be announced

  • This webinar is designed to provide detailed information on the background to the call for proposals, its objectives, eligibility criteria, funding, submission process, timeline, etc.
  • The webinar will provide a platform to engage with the organisers, ask specific questions and obtain advice on maximising proposals’ chances of success.

Programme

Forthcoming (late November)

Practical information

Full details of this call for proposals are provided in the regulations available below.

Who can apply?

Submitted projects must be collaborative and involve a French research team and a German research team, which will jointly coordinate the project. Additional research teams, up to two per country, may be included as partners where their participation is scientifically justified.

How to submit a project

Applications must be written in English and submitted through the ANRS MIE Apogée platform between 26 October 2026 and 12 January 2027. Prior registration on the Apogée platform is required to submit an application.

The complete application comprises:

  • a scientific proposal, written using the required template and uploaded to Apogée;
  • a budget broken down by team, entered directly online on Apogée;
  • a letter of commitment signed by each partner and their institution, uploaded to Apogée.

Only electronic versions of documents submitted through Apogée before the closing date will be considered.

Submit my project

How are projects evaluated?

Applications will be evaluated by a committee of independent international experts according to the following criteria: the project’s scientific excellence, its feasibility in light of the consortium’s resources and expertise, its impact on progress towards a cure and on strengthening Franco-German collaboration, as well as its innovative nature and potential for clinical development.

Consult the regulations and documents for this call

  • Letter of commitment (forthcoming)

Contacts